Close

Synergy Pharmaceuticals Inc. (SGYP) Initiates Second Pivotal Plecanatide Phase 3

April 28, 2014 9:27 AM EDT Send to a Friend
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced the start of its second pivotal phase 3 clinical trial to confirm the safety ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login